Piper Sandler reiterated coverage on Houlihan Lokey with a new price target
$HLI
Investment Managers
Finance
Piper Sandler reiterated coverage of Houlihan Lokey with a rating of Neutral and set a new price target of $106.00 from $122.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/13/2025 | $201.00 → $190.00 | Underweight → Overweight | Morgan Stanley |
| 3/11/2025 | $180.00 → $179.00 | Underweight → Overweight | Wells Fargo |
| 12/9/2024 | $171.00 → $200.00 | Equal-Weight → Underweight | Morgan Stanley |
| 9/12/2024 | $149.00 | Underweight | Wells Fargo |
| 1/29/2024 | Mkt Perform | Keefe Bruyette | |
| 7/18/2022 | $95.00 → $82.00 | Underweight → Equal-Weight | Morgan Stanley |
| 4/7/2022 | $92.00 → $76.00 | Neutral → Underweight | Piper Sandler |
| 3/9/2022 | $122.00 → $106.00 | Neutral | Piper Sandler |
10-K - HOULIHAN LOKEY, INC. (0001302215) (Filer)
SCHEDULE 13G/A - HOULIHAN LOKEY, INC. (0001302215) (Subject)
8-K - HOULIHAN LOKEY, INC. (0001302215) (Filer)
Morgan Stanley upgraded Houlihan Lokey from Underweight to Overweight and set a new price target of $190.00 from $201.00 previously
Wells Fargo upgraded Houlihan Lokey from Underweight to Overweight and set a new price target of $179.00 from $180.00 previously
Morgan Stanley downgraded Houlihan Lokey from Equal-Weight to Underweight and set a new price target of $200.00 from $171.00 previously
4 - HOULIHAN LOKEY, INC. (0001302215) (Issuer)
4 - HOULIHAN LOKEY, INC. (0001302215) (Issuer)
4 - HOULIHAN LOKEY, INC. (0001302215) (Issuer)